US
Noting the Mag 7 are doing well again; it’s worth keeping in mind (at least, the back of the mind) that US macro data sure looks to be moderating (some say “stall speed”) and that advertising is often at the heart of the various business models on show here.
META (Facebook) has cyclicality, and if the US economy heads south, it matters. Amazon, Meta, they certainly have pricing power, and are far stronger than some old legacy media or retail business, especially in the face of a recession. But nor are they immune, which is why valuation does (or should) have some bearing here, especially given the degree of concentration risk in the index.

The way we’ve tried to position is something like “maybe the AI gains are broadly dispersed throughout the economy, and so maybe the big returns on the enormous Mag 7 capex won’t really accrue to just them” + “the base businesses of the Mag 7 names are doing really well (which is why they are doing all that capex, they are trying to put a stranglehold on those moats) and are presently printing money, but they aren’t immune to the cycle, so we shouldn’t pay too much for them” + “because they are such a large part of the index, we get tonnes of exposure via the benchmark, and maybe if we are wrong that means we do less than a fund that is very long Mag 7, but we certainly won’t do too poorly. 20% of infinity is still infinity“.
Aus PMI
Strong prints for the Aussie S&P Global PMI data. Between this, approvals, credit + retail sales, you’d be arguing the +20bps in the unemployment rate was more noise than signal.

Important Information: This document has been prepared by Aequitas Investment Partners Pty Ltd ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of AIP FS Pty Ltd ABN 49 680 982 478 (Australian Financial Services Licensee no. 700016) and is for distribution within Australia to wholesale clients only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Aequitas is not authorised to provide tax (financial) advice and is not a registered tax agent. Investors should seek their own tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law. We recommend that you consult a registered tax agent or a tax specialist to confirm your taxation position.